In a Ph-positive CML expression of the BCR/ABL chimeric protein p210 with an increased tyrosine kinase activity is essential for multiple signaling pathways to confer the leukemia phenotype [3]. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.